Resumen

LISBONA GIL, A. et al. Type 2 diabetes: new anti-diabetics and therapeutic strategy for military pilots and planes, combat vehicles and warship crews. Sanid. Mil. [online]. 2014, vol.70, n.4, pp.282-287. ISSN 1887-8571.  https://dx.doi.org/10.4321/S1887-85712014000400008.

The training of combat, transport or helicopter pilots and flight, combat vehicles and warship crews imply a big effort in terms of economic resources, time and logistics for our Armed Forces (FAS). Therefore, it is the responsibility of the Military Health Service to maintain the aptitudes and the skills of our personnel in the best possible conditions for the longest period of time, thus procuring the maximum operating capacity required for the accomplishment of their missions. In this paper it is reviewed and proposed anti-diabetic drugs that may be safely used by pilots, flight, combat vehicles and warship crews, appreciating those that do not produce hypoglycemia neither cause side effects that can compromise the operating capacity. It is recommended and encouraged personnel with pre-diabetic condition to modify their life style and to initiate treatment with metformin, in order to delay or to avoid the onset of diabetes and extend their operating life. It is also encouraged the use of those anti-diabetic agents that best preserve the function of the pancreatic beta cell, therefore delaying the need for insulin based therapy.

Palabras clave : type 2 diabetes; Military pilots; Flight crews; Combat vehicles crews; Warship crews.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )